Literature DB >> 11408066

DNA copy number profiling in esophageal Barrett adenocarcinoma: comparison with gastric adenocarcinoma and esophageal squamous cell carcinoma.

A Varis1, P Puolakkainen, H Savolainen, A Kokkola, J Salo, O Nieminen, S Nordling, S Knuutila.   

Abstract

We screened 18 specimens of Barrett adenocarcinoma for genetic alterations using comparative genomic hybridization (CGH) to analyze DNA copy number changes. The most common gains were at 20q (56%) and 17q (39%). High-level amplifications were observed in the same chromosomes. The most common losses were in chromosomes 4 (22%) and 5 (22%). Other recurrent changes were gains of chromosomes 8, 10q, and 13. We compared the copy number changes in Barrett adenocarcinoma and those previously reported in the intestinal type of stomach carcinoma. The similarities we found suggest a common molecular pathogenesis, whereas dissimilarities seen between Barrett adenocarcinoma and esophageal squamous cell carcinoma are in keeping with a well-known different etiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408066     DOI: 10.1016/s0165-4608(00)00423-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

1.  Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation.

Authors:  Ryoji Kushima; Michael Vieth; Ken-Ichi Mukaisho; Rie Sakai; Hidetoshi Okabe; Takanori Hattori; Horst Neuhaus; Franz Borchard; Manfred Stolte
Journal:  Virchows Arch       Date:  2005-04-19       Impact factor: 4.064

Review 2.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

3.  The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus.

Authors:  Shannon M Brankley; Kenneth K Wang; Aaron R Harwood; Dylan V Miller; Mona S Legator; Lori S Lutzke; Benjamin R Kipp; Larry E Morrison; Kevin C Halling
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

4.  Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapies.

Authors:  Patrick M Forde; Ronan J Kelly
Journal:  Oncologist       Date:  2013-07-12

5.  Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.

Authors:  Patrapim Sunpaweravong; Somkiat Sunpaweravong; Puttisak Puttawibul; Winyou Mitarnun; Chan Zeng; Anna E Barón; Wilbur Franklin; Sherif Said; Marileila Varella-Garcia
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-19       Impact factor: 4.553

6.  Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.

Authors:  William W Lockwood; Kelsie L Thu; Lin Lin; Larissa A Pikor; Raj Chari; Wan L Lam; David G Beer
Journal:  Clin Cancer Res       Date:  2012-02-10       Impact factor: 12.531

7.  Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.

Authors:  Tadayuki Akagi; Tetsuo Ito; Motohiro Kato; Zhe Jin; Yulan Cheng; Takatsugu Kan; Go Yamamoto; Alexandru Olaru; Norihiko Kawamata; Jessica Boult; Harmik J Soukiasian; Carl W Miller; Seishi Ogawa; Stephen J Meltzer; H Phillip Koeffler
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

Review 8.  State of the art management of metastatic gastroesophageal cancer.

Authors:  Adrian G Murphy; David Lynch; Ronan J Kelly
Journal:  Ann Transl Med       Date:  2015-09

9.  Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Thomas G Paulson; Carlo C Maley; Xiaohong Li; Hongzhe Li; Carissa A Sanchez; Dennis L Chao; Robert D Odze; Thomas L Vaughan; Patricia L Blount; Brian J Reid
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

10.  DNA copy number changes in young gastric cancer patients with special reference to chromosome 19.

Authors:  A Varis; B van Rees; M Weterman; A Ristimäki; J Offerhaus; S Knuutila
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.